Literature DB >> 25810474

Challenges and Potential for Ovarian Preservation with SERMs.

Alison Y Ting1, Brian K Petroff2.   

Abstract

Tamoxifen (TAM) is a selective estrogen receptor modulator with tissue-specific effects on estrogen signaling used predominantly for treatment and chemoprevention of breast cancers. Recent studies have shown that TAM prevents infertility and decreases follicular loss from common cancer chemotherapy and radiation therapy in preclinical models. Here we review current and novel uses of selective estrogen receptor modulator s and advantages and challenges for translation of TAM for human fertility preservation.
© 2015 by the Society for the Study of Reproduction, Inc.

Entities:  

Keywords:  SERM; cancer; fertility; ovary; tamoxifen

Mesh:

Substances:

Year:  2015        PMID: 25810474      PMCID: PMC4645985          DOI: 10.1095/biolreprod.115.128207

Source DB:  PubMed          Journal:  Biol Reprod        ISSN: 0006-3363            Impact factor:   4.285


  108 in total

1.  Induction of puberty by autograft of cryopreserved ovarian tissue.

Authors:  Catherine Poirot; Fadi Abirached; Marie Prades; Christiane Coussieu; Françoise Bernaudin; Pascal Piver
Journal:  Lancet       Date:  2012-02-11       Impact factor: 79.321

2.  Reproduction post-chemotherapy in young cancer patients.

Authors:  D Meirow
Journal:  Mol Cell Endocrinol       Date:  2000-11-27       Impact factor: 4.102

3.  Short-term tamoxifen plus chemotherapy: superior results in node-positive breast cancer.

Authors:  J P Crowe; N H Gordon; R R Shenk; R W Soegiarso; C A Hubay; E G Mansour; J M Shuck; O H Pearson; J S Marshall; B Arafah
Journal:  Surgery       Date:  1990-10       Impact factor: 3.982

4.  High-dose estrogen and clinical selective estrogen receptor modulators induce growth arrest, p21, and p53 in primate ovarian surface epithelial cells.

Authors:  Jay W Wright; Richard L Stouffer; Karin D Rodland
Journal:  J Clin Endocrinol Metab       Date:  2005-03-08       Impact factor: 5.958

5.  Tamoxifen co-administration during controlled ovarian hyperstimulation for in vitro fertilization in breast cancer patients increases the safety of fertility-preservation treatment strategies.

Authors:  Dror Meirow; Hila Raanani; Ettie Maman; Shani Paluch-Shimon; Moran Shapira; Yoram Cohen; Irena Kuchuk; Ariel Hourvitz; Jacob Levron; Michal Mozer-Mendel; Masha Brengauz; Hana Biderman; Daphna Manela; Rephael Catane; Jehoshua Dor; Raoul Orvieto; Bella Kaufman
Journal:  Fertil Steril       Date:  2014-06-14       Impact factor: 7.329

Review 6.  Gonadotropin-releasing hormone analogues for the prevention of chemotherapy-induced premature ovarian failure in cancer women: systematic review and meta-analysis of randomized trials.

Authors:  Lucia Del Mastro; Marcello Ceppi; Francesca Poggio; Claudia Bighin; Fedro Peccatori; Isabelle Demeestere; Alessia Levaggi; Sara Giraudi; Matteo Lambertini; Alessia D'Alonzo; Giuseppe Canavese; Paolo Pronzato; Paolo Bruzzi
Journal:  Cancer Treat Rev       Date:  2013-12-08       Impact factor: 12.111

7.  N,N-diethyl-2-[4-(phenylmethyl) phenoxy] ethanamine (DPPE; tesmilifene), a chemopotentiating agent with hormetic effects on DNA synthesis in vitro, may improve survival in patients with metastatic breast cancer.

Authors:  Lorne J Brandes
Journal:  Hum Exp Toxicol       Date:  2008-02       Impact factor: 2.903

8.  A phase I trial of high-dose oral tamoxifen and CHOPE.

Authors:  D C Smith; D L Trump
Journal:  Cancer Chemother Pharmacol       Date:  1995       Impact factor: 3.333

9.  Randomized clinical trial of cyclophosphamide, 5-FU, and prednisone with or without tamoxifen in postmenopausal women with advanced breast cancer.

Authors:  J E Krook; J N Ingle; S J Green; W D Bowman; L K Everson; H E Windschitl; R F Marschke; J A Laurie; S A Cullinan; D M Pfeifle
Journal:  Cancer Treat Rep       Date:  1985-04

Review 10.  Preservation of fertility in patients with cancer.

Authors:  Jacqueline S Jeruss; Teresa K Woodruff
Journal:  N Engl J Med       Date:  2009-02-26       Impact factor: 91.245

View more
  2 in total

1.  Impact of tamoxifen therapy on fertility in breast cancer survivors.

Authors:  Lisa M Shandley; Jessica B Spencer; Amy Fothergill; Ann C Mertens; Amita Manatunga; Elisavet Paplomata; Penelope P Howards
Journal:  Fertil Steril       Date:  2016-11-22       Impact factor: 7.329

2.  LH prevents cisplatin-induced apoptosis in oocytes and preserves female fertility in mouse.

Authors:  Valerio Rossi; Monica Lispi; Salvatore Longobardi; Maurizio Mattei; Francesca Di Rella; Antonietta Salustri; Massimo De Felici; Francesca G Klinger
Journal:  Cell Death Differ       Date:  2016-09-30       Impact factor: 15.828

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.